325 related articles for article (PubMed ID: 25708992)
1. Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.
Li H; Zhang X; Park P; Liu W; Chang J; Liao Z; Frank S; Li Y; Poenisch F; Mohan R; Gillin M; Zhu R
Radiother Oncol; 2015 Mar; 114(3):367-72. PubMed ID: 25708992
[TBL] [Abstract][Full Text] [Related]
2. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
3. Energy layer optimization strategies for intensity-modulated proton therapy of lung cancer patients.
Jensen MF; Hoffmann L; Petersen JBB; Møller DS; Alber M
Med Phys; 2018 Oct; 45(10):4355-4363. PubMed ID: 30129041
[TBL] [Abstract][Full Text] [Related]
4. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.
Shan J; Sio TT; Liu C; Schild SE; Bues M; Liu W
Med Phys; 2019 Jan; 46(1):382-393. PubMed ID: 30387870
[TBL] [Abstract][Full Text] [Related]
5. Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.
Liu W; Liao Z; Schild SE; Liu Z; Li H; Li Y; Park PC; Li X; Stoker J; Shen J; Keole S; Anand A; Fatyga M; Dong L; Sahoo N; Vora S; Wong W; Zhu XR; Bues M; Mohan R
Pract Radiat Oncol; 2015; 5(2):e77-86. PubMed ID: 25413400
[TBL] [Abstract][Full Text] [Related]
6. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
Bai X; Lim G; Grosshans D; Mohan R; Cao W
Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
[TBL] [Abstract][Full Text] [Related]
7. Multiple-CT optimization of intensity-modulated proton therapy - Is it possible to eliminate adaptive planning?
Wang X; Li H; Zhu XR; Hou Q; Liao L; Jiang B; Li Y; Wang P; Lang J; Zhang X
Radiother Oncol; 2018 Jul; 128(1):167-173. PubMed ID: 29054378
[TBL] [Abstract][Full Text] [Related]
8. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
[TBL] [Abstract][Full Text] [Related]
9. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
An Y; Liang J; Schild SE; Bues M; Liu W
Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
[TBL] [Abstract][Full Text] [Related]
11. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
12. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
[TBL] [Abstract][Full Text] [Related]
13. An uncertainty-incorporated method for fast beam angle selection in intensity-modulated proton therapy.
Ramar N; Meher SR
J Cancer Res Ther; 2023; 19(3):688-696. PubMed ID: 37470595
[TBL] [Abstract][Full Text] [Related]
14. Robust optimization of intensity modulated proton therapy.
Liu W; Zhang X; Li Y; Mohan R
Med Phys; 2012 Feb; 39(2):1079-91. PubMed ID: 22320818
[TBL] [Abstract][Full Text] [Related]
15. Anatomical robust optimization to account for nasal cavity filling variation during intensity-modulated proton therapy: a comparison with conventional and adaptive planning strategies.
van de Water S; Albertini F; Weber DC; Heijmen BJM; Hoogeman MS; Lomax AJ
Phys Med Biol; 2018 Jan; 63(2):025020. PubMed ID: 29160775
[TBL] [Abstract][Full Text] [Related]
16. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
[TBL] [Abstract][Full Text] [Related]
17. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study.
Yeung D; McKenzie C; Indelicato DJ
Pediatr Blood Cancer; 2014 Jan; 61(1):89-94. PubMed ID: 24000229
[TBL] [Abstract][Full Text] [Related]
18. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
19. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
20. Including anatomical variations in robust optimization for head and neck proton therapy can reduce the need of adaptation.
Cubillos-Mesías M; Troost EGC; Lohaus F; Agolli L; Rehm M; Richter C; Stützer K
Radiother Oncol; 2019 Feb; 131():127-134. PubMed ID: 30773179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
